StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Tempest Therapeutics, Inc.
NasdaqCM:TPST
Sector
Industries
Location
Market Cap
USD 27.40 M
Share Price
USD 7.44
Avg Daily Volume
120,730
Change (1 day)
5.08%
Change (1 year)
Change (YTD)
-30.27%
Tempest Therapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -33.88 M
Tempest Therapeutics, Inc. Operating Cash Flow is USD -33.88 M for the Trailing 12 Months (TTM) ending March 31, 2025. Operating cash flow is cash generated from the company’s regular business operations.
-
Tempest Therapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -32.27 M, a 20.61% change year over year.
-
Tempest Therapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -26.75 M, a 34.78% change year over year.
-
Tempest Therapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -19.85 M, a -45.01% change year over year.
Competitors
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Thermo Fisher Scientific Inc.
USD 426.17
TMO
+7.47
1.78%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Boston Scientific Corporation
USD 102.41
BSX
-1.42
-1.37%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
CSL Limited
USD 159.49
CSL.AX
-1.10
-0.69%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Siemens Healthineers AG
USD 55.00
SHL.DE
+0.44
0.81%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Thermo Fisher Scientific Inc.
USD 426.17
TMO
+7.47
1.78%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Boston Scientific Corporation
USD 102.41
BSX
-1.42
-1.37%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
CSL Limited
USD 159.49
CSL.AX
-1.10
-0.69%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Siemens Healthineers AG
USD 55.00
SHL.DE
+0.44
0.81%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%